포스포아미다이트 시장 : 업계 동향과 세계 예측(-2035년) - 포스포아미다이트 유형별, 합성 올리고뉴클레오티드 유형별, 용도별, 치료 분야별, 지역별
Phosphoramidites Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Phosphoramidite, Type of Oligonucleotide synthesized, Application Area, Therapeutic Area and Geographical Regions
상품코드:1817401
리서치사:Roots Analysis
발행일:2025년 09월
페이지 정보:영문 216 Pages
라이선스 & 가격 (부가세 별도)
한글목차
포스포아미드 시장 : 개요
포스포아미다이트 시장 규모는 2024년 8억 달러에서 2025년에는 10억 달러, 2035년에는 27억 달러로 성장할 것으로 추정되며, 예측 기간 중 CAGR은 10.6%에 달할 전망입니다.
포스포아미드 시장 기회는 다음과 같은 부문으로 나뉩니다.
포스포아미타이트 유형
DNA 포스포아미타이트
RNA 포스포아미다이트
2'-변성 포스포아미타이트
락드핵산(LNA)
기타 포스포아미타이트
올리고뉴클레오티드 유형
siRNA 올리고뉴클레오티드
안티센스 올리고뉴클레오티드
DNA 올리고뉴클레오티드
기타 올리고뉴클레오티드
용도
조사 및 진단 용도
상업적 치료 응용
임상 치료 응용
치료 영역
감염성 질환
심혈관 질환
유전자 질환
대사성 질환
간 질환
자가면역질환
종양학 질환
신장질환
안과 질환
신경계 질환
혈액 질환
기타
지역
북미
유럽
아시아태평양
라틴아메리카
중동 및 북아프리카
북미 시장
미국
캐나다
유럽 시장
독일
프랑스
영국
이탈리아
스페인
기타 유럽
아시아태평양 시장
중국
일본
인도
한국
호주
기타
라틴아메리카 시장
브라질
아르헨티나
멕시코
기타
중동 및 북아프리카 시장
이집트
이스라엘
사우디아라비아
기타
포스포아미드 시장 성장 및 동향
포스포아미다이트(또는 아미다이트)는 화학적으로 변형된 뉴클레오시드로, 인산염기와 여러 개의 보호기를 가지고 있으며, 올리고뉴클레오티드 합성의 구성 요소로 작용합니다. 이러한 포스포아미다이트는 맞춤형 DNA 및 RNA 서열을 만드는 데 매우 중요한 역할을 합니다. 1981년 도입된 포스포아미드 화학은 순차적, 제어된 자동 DNA/RNA 합성을 가능하게 하여 분자생물학에 혁명을 일으켰습니다.
포스포아미다이트 화학의 적응성은 그 효과, 높은 수율, 변형된 뉴클레오티드를 통합하는 능력에 의해 입증되었습니다. 이 때문에 분자생물학, 생명공학, 의학 등 다양한 분야에서 필수 불가결한 존재가 되고 있습니다. 특정 조건에서 포스포아미다이트의 명확한 안정성과 반응성은 현대 올리고뉴클레오티드 합성의 기본 구성 요소로 자리 매김했습니다. 이를 통해 합성화학, 분자진단, 맞춤치료 등 다양한 용도의 올리고뉴클레오티드 생산이 용이해집니다.
포스포아미다이트는 유전자 치료, 맞춤의료, 신약개발에 중요한 역할을 할 것으로 기대하고 있습니다. 기술의 발전과 함께 포스포아미다이트의 용도는 계속 확대될 것이며, 궁극적으로 분자생물학 분야의 연구개발 혁신을 촉진할 것으로 보입니다.
포스포아미드 시장 주요 인사이트
이 보고서는 포스포아미타이트 시장의 현황을 조사하고 업계의 잠재적 성장 기회를 파악합니다. 이 보고서의 주요 내용은 다음과 같습니다.
현재 다양한 지역의 85개사가 올리고뉴클레오티드 합성을 포함한 수많은 생화학 용도에 포스포아미데이트를 공급/제조하고 있습니다.
70% 이상의 기업이 DNA 올리고뉴클레오티드 합성을 위해 포스포아미데이트를 제공하고 있으며, 이는 DNA 합성 화학 분야에서 수요가 증가하고 있음을 보여줍니다.
이 분야에 대한 관심이 높아지고 있다는 것은 최근 수년간 설립된 파트너십을 통해도 알 수 있는데, 특히 인수가 가장 일반적인 파트너십 모델 유형으로 부상하고 있습니다.
포스포아미타이트 분야에서 공개된 특허의 약 80%는 특허 출원이며, 특히 지난해 공개된 특허가 대부분(46%)을 차지합니다.
2035년까지 수요의 45% 가량이 북미에서 발생할 것으로 예측됩니다. 특히 아시아태평양의 포스포아미드 수요는 연평균 15.2%의 성장률을 보일 것으로 예측됩니다.
올리고뉴클레오티드 합성에서 포스포아미다이트에 대한 수요가 빠르게 증가함에 따라 시장은 2035년까지 연평균 10.6%의 성장률을 보일 것으로 예측됩니다.
포스포아미타이트 시장 주요 분야
포스포아미타이트 유형별로 세계 시장은 DNA 포스포아미타이트, RNA 포스포아미타이트, 2'-변형 포스포아미타이트, 락드핵산(LNA), 기타 포스포아미타이트 등으로 분류됩니다. 현재 DNA 포스포아미타이트가 시장 점유율의 40%를 차지하고 있습니다. 이는 높은 반응성으로 인한 올리고뉴클레오티드 합성에 대한 활력으로 진단, 치료, 연구 등 다양한 용도의 고품질 올리고뉴클레오티드의 제조가 가능합니다.
합성 올리고뉴클레오티드 유형별로 세계 시장은 siRNA 올리고뉴클레오티드, 안티센스 올리고뉴클레오티드, DNA 올리고뉴클레오티드, 기타 올리고뉴클레오티드 등으로 구분됩니다. 현재 siRNA 올리고뉴클레오티드가 전체 시장의 약 45%의 점유율을 차지하고 있습니다. 이러한 올리고뉴클레오티드는 비교적 간단한 작용기전을 가지고 있으며, 강력한 분자를 식별할 수 있기 때문입니다. 또한 이러한 올리고뉴클레오티드는 높은 효능을 가진 비 변형 RNA의 제조가 용이합니다.
용도별로 세계 시장은 연구 및 진단용, 상업적 치료용, 임상 치료용으로 구분됩니다. 현재 연구 및 진단 용도가 전체 시장의 60% 이상을 차지하고 있습니다. 이는 포스포아미다이트의 효율성, 확장성, 하이스루풋 공정에 대한 적합성 등의 이유로 포스포아미다이트의 대부분이 연구 및 진단 용도로 활용되고 있기 때문입니다.
치료 분야별로 전체 시장은 감염성 질환, 심혈관 질환, 유전성 질환, 대사성 질환, 간 질환, 자가면역 질환, 종양성 질환, 신장질환, 안과 질환, 신경질환, 혈액 질환, 기타 질환으로 구분됩니다. 이는 병원체 검출 및 질병 관리를 가능하게 하는 PCR 등 진단 검사에서 포스포아미타이트가 매우 중요한 역할을 하기 때문입니다.
지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동, 북아프리카 등 다양한 지역에 걸쳐 세계 시장이 형성되어 있습니다. 당사의 예측에 따르면 올해 북미가 포스포아미드 시장 점유율의 대부분(45%)을 차지할 것으로 예상되며, 이러한 추세는 앞으로도 변하지 않을 것으로 예측됩니다. 또한
아시아태평양 시장은 예측 기간 중 비교적 높은 CAGR(11.8%)로 성장할 것으로 예측됩니다.
포스포아미드 시장 진출기업 사례
Aurisco Pharmaceutical
BOC Sciences
Innovassynth Technologies
Merck
Meridian Biosciences
Promega
QIAGEN
Roche
Thermo Fisher Scientific
WuXi AppTech
Yamasa
Zhejiang Hengkang Pharmaceutical
목차
섹션 1 리포트 개요
제1장 서문
제2장 조사 방법
제3장 시장 역학
챕터 개요
예측 조사 방법
시장 평가 프레임워크
예측 툴과 테크닉
주요 고려사항
제한 사항
제4장 거시경제 지표
챕터 개요
시장 역학
결론
섹션 2 정성적 인사이트
제5장 개요
제6장 서론
포스포아미다이트의 개요
올리고뉴클레오티드 합성을 위한 포스포아미다이트법
포스포아미다이트의 이점
포스포아미다이트의 응용
포스포아미다이트에 관련된 과제
최근 동향
섹션 3 시장 개요
제7장 시장 구도
포스포아미다이트 프로바이더/제조업체 : 시장 구도
제8장 기업 경쟁력 분석
조사 방법과 주요 파라미터
스코어링
피어 그룹의 개요
포스포아미다이트 프로바이더/제조업체 : 기업 경쟁력 분석
섹션 4 기업 개요
제9장 기업 개요 : 북미에 기반을 둔 기업
Meridian Life Sciences
Promega
BOC Sciences
Thermo Fisher Scientific
제10장 기업 개요 : 유럽에 기반을 둔 기업
Roche
Merck
QIAGEN
제11장 기업 개요 : 아시아태평양에 기반을 둔 기업
Aurisco Pharmaceuticals
Innovassynth
YAMASA
WuXi AppTech
Zhejiang Hengkang Pharmaceutical
섹션 5 시장 동향
제12장 최근 동향
챕터 개요
파트너십 모델
포스포아미다이트 : 파트너십과 협업
자금조달과 투자 모델
확장 모델
제13장 특허 분석
범위와 조사 방법
포스포아미다이트 : 특허 분석
특허 벤치마킹 분석
특허 평가
인용수 상위 특허
섹션 6 시장 기회 분석
제14장 시장 영향 분석 : 촉진요인, 억제요인, 기회, 과제
제15장 수요 분석
주요 전제와 조사 방법
포스포아미다이트의 세계 연간 수요(단위 : 메트릭톤)
제16장 세계의 포스포아미다이트 시장
주요 전제와 조사 방법
세계의 포스포아미다이트 시장, 역사적 동향(2023년 이후) 및 예측(2035년까지)
주요 시장 세분화
제17장 포스포아미다이트 시장(포스포아미다이트 유형별)
제18장 포스포아미다이트 시장(합성 올리고뉴클레오티드 유형별)
제19장 포스포아미다이트 시장(용도별)
제20장 포스포아미다이트 시장(치료 분야별)
제21장 포스포아미다이트 시장(주요 지역별)
제22장 보고서 결론
섹션 7 부록
제23장 표형식 데이터
제24장 도표
제25장 기업·단체 리스트
KSA
영문 목차
영문목차
PHOSPHORAMIDITES MARKET: OVERVIEW
As per Roots Analysis, the phosphoramidites market is estimated to grow from USD 0.8 billion in 2024 to 1.0 billion in 2025 and USD 2.7 billion by 2035, representing a CAGR of 10.6% during the forecast period.
The opportunity for phosphoramidites market has been distributed across the following segments:
Type of Phosphoramidite
DNA Phosphoramidites
RNA Phosphoramidites
2'-Modified Phosphoramidites
Locked Nucleic Acid (LNA)
Other Phosphoramidites
Type of Oligonucleotide Synthesized
siRNA Oligonucleotides
Antisense Oligonucleotides
DNA Oligonucleotides
Other Oligonucleotides
Application Area
Research and Diagnostic Applications
Commercial Therapeutic Applications
Clinical Therapeutic Applications
Therapeutic Area
Infectious Diseases
Cardiovascular Disorders
Genetic Disorders
Metabolic Disorders
Liver Disorders
Autoimmune Disorders
Oncological Disorders
Nephrological Disorders
Ophthalmological Disorders
Neurological Disorders
Hematological Disorders
Other Disorders
Geographical Regions
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
Market in North America
US
Canada
Market in Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Market in Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
Market in Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Market in Middle East and North Africa
Egypt
Israel
Saudi Arabia
Rest of Middle East and North Africa
Phosphoramidites Market: Growth and Trends
Phosphoramidites (or amidites) are chemically modified nucleosides that contain a phosphite group and several protecting groups serving as the building blocks of oligonucleotide synthesis. These phosphoramidites play a pivotal role in creating custom DNA and RNA sequences. Introduced in 1981, phosphoramidite chemistry has revolutionized molecular biology by enabling sequential, controlled and automated DNA / RNA synthesis.
The adaptability of phosphoramidite chemistry is demonstrated by its effectiveness, high yield, and capability to integrate modified nucleotides. This makes it indispensable in various fields, including molecular biology, biotechnology and medicine. The well-defined stability and reactivity of phosphoramidites under certain conditions have established them as fundamental components in modern oligonucleotide synthesis. This facilitates the production of oligonucleotides for various applications including synthetic chemistry, molecular diagnostics and personalized therapeutics.
We anticipate phosphoramidites to play a critical role in gene therapy and personalized medicine as well as in novel drug development. With the advancements in technology, the applications of phosphoramidites will continue to expand, ultimately driving the innovation in research and development within molecular biology.
Phosphoramidites Market: Key Insights
The report delves into the current state of the phosphoramidite market and identifies potential growth opportunities within the industry. The key takeaways of the report are:
At present, 85 companies located across different regions are providing / manufacturing phosphoramidites for a myriad of biochemical applications, including oligonucleotide synthesis.
More than 70% of the companies provide phosphoramidites for the synthesis of DNA oligonucleotides, highlighting their rising demand in DNA synthesis chemistry.
The growing interest in this domain is evident from the partnerships established in recent years; notably, acquisitions emerged as the most common type of partnership model.
Around 80% of the patents published in the phosphoramidites domain are patent applications; notably, majority (46%) of the patents were published last year.
By 2035, close to 45% of the demand is anticipated to be generated in North America; notably, demand for phosphoramidites in Asia-Pacific is projected to grow at a CAGR of 15.2%.
Given the rapid increase in the demand for phosphoramidites in oligonucleotide synthesis, the market is poised to grow at a CAGR of 10.6% till 2035.
Phosphoramidites Market: Key Segments
DNA Phosphoramidites Segment Holds the Largest Market Share
Based on the type of phosphoramidite, the global market is segmented DNA phosphoramidites, RNA phosphoramidites, 2'-modified phosphoramidites, locked nucleic acid (LNA) and other phosphoramidites. In the current year, DNA phosphoramidites capture 40% of the market share. This can be attributed to their vitality in oligonucleotide synthesis due to their reactivity, which enables the production of high-quality oligonucleotides for various applications, such as diagnostics, therapeutics and research.
siRNA Oligonucleotides Segment is likely to Dominate the Overall Market
Based on the type of oligonucleotide synthesized, the global market is segmented into siRNA oligonucleotides, antisense oligonucleotides, DNA oligonucleotides and other oligonucleotides. Currently, siRNA oligonucleotides hold nearly 45% of the overall market share, as these oligonucleotides have relatively simple mechanism of action for identifying potent molecules. In addition, these oligonucleotides offer an ease in producing unmodified RNA with high potency.
Research and Diagnostic Applications Segment to Hold the Highest Market Share
Based on the application areas, the global market is segmented into research and diagnostic applications, commercial therapeutic applications and clinical therapeutic applications. Presently, research and diagnostic applications segment captures more than 60% of the overall market share. This can be attributed to the fact that majority of phosphoramidites are utilized for research and diagnostic purposes, owing to their efficiency, scalability and compatibility for high-throughput processes.
Hematological Disorders Segment to Grow at a Higher CAGR
Based on the therapeutic area, the overall market is segmented across infectious diseases, cardiovascular disorders, genetic disorders, metabolic disorders, liver disorders, autoimmune disorders, oncological disorders, nephrological disorders, ophthalmological disorders, neurological disorders, hematological disorders and other disorders. In the current year, infectious diseases segment captures 25% of the overall market share, owing to the pivotal role of phosphoramidites in diagnostic tests like PCR, which enables pathogen detection and disease control.
Asia-Pacific to Propel in the Phosphoramidites Sector in the Coming Years
Based on the geographical regions, the global market across various geographies, such as North America, Europe, Asia-Pacific, Latin America and Middle East, and North Africa. According to our projections, we anticipate North America to capture the majority of the phosphoramidite market share (45%) in the current year and this trend is unlikely to change in the future. Further,
The market in Asia-Pacific is likely to grow at a relatively higher CAGR (11.8%), during the forecast period.
Example Players in the Phosphoramidites Market
Aurisco Pharmaceutical
BOC Sciences
Innovassynth Technologies
Merck
Meridian Biosciences
Promega
QIAGEN
Roche
Thermo Fisher Scientific
WuXi AppTech
Yamasa
Zhejiang Hengkang Pharmaceutical
PHOSPHORAMIDITES MARKET: RESEARCH COVERAGE
The report on Phosphoramidites Market features insights into various sections, including:
Market Sizing and Opportunity Analysis: An in-depth analysis of current market opportunity and the future growth potential of phosphoramidites market, focusing on key market segments, including [A] type of phosphoramidite, [B] type of oligonucleotide synthesized, [C] application area, [D] therapeutic area, and [E] geographical regions.
Market Landscape: A comprehensive evaluation of phosphoramidites, based on several relevant parameters, such as [A] type of offering, [B] type of building block offered, [C] type of molecule, [D] type of oligonucleotide synthesized, [E] application area [F] and type of service offered.
Phosphoramidites Developer Landscape: The report features a list of system providers engaged in the phosphoramidites domain, along with analyses based on [A] year of establishment, [B] company size, and [C] location of headquarters.
Company Competitiveness Analysis: An insightful competitiveness analysis of the phosphoramidite providers / manufacturers based across various geographies namely [A] North America [B] Europe, and [C] Asia-Pacific.
Company Profiles: Comprehensive profiles of key industry players in the phosphoramidites domain based across various geographies, featuring information on [A] company overview, [B] financial information (if available), [C] service and product portfolio, [D] recent developments, and [E] future outlook statements.
Recent Developments: A detailed analysis of partnerships inked between stakeholders in the phosphoramidites market, based on several relevant parameters, such as [A] year of partnership, [B] type of partnership, [C] and geography. In addition, the module also features information on funding and expansions reported in this domain.
Patent Analysis: A detailed analysis of the various patents filed / granted in the phosphoramidites domain, based on several relevant parameters, such as [A] type of patent, [B] patent application year, [C] patent age, [D] type of applicant, [E] patent jurisdiction, [F] patent benchmarking analysis and [G] patent valuation.
Market Impact Analysis: A thorough analysis of various factors, such as [A] drivers, [B] restraints, [C] opportunities, and [D] existing challenges that are likely to impact market growth.
Key Questions Answered in this Report
How many companies are currently engaged in this market?
Which are the leading companies in this market?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?
Reasons to Buy this Report
The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
Additional Benefits
Complimentary Excel Data Packs for all Analytical Modules in the Report
15% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older
TABLE OF CONTENTS
SECTION I: REPORT OVERVIEW
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
2.5. Robust Quality Control
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting the Market
4.2.2.2. Factors Affecting Currency Fluctuations in the Industry
4.2.2.3. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
4.2.8.5. Impact of Trade Barriers on the Market
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross Border Dynamics
4.3. Conclusion
SECTION II: QUALITATIVE INSIGHTS
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. An Overview of Phosphoramidites
6.2. Phosphoramidite Method for Oligonucleotide Synthesis
7.1.7. Analysis by Type of Oligonucleotide Synthesized
7.1.8. Analysis by Application Area
7.1.9. Analysis by Type of Service Offered
8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Methodology and Key Parameters
8.2. Scoring
8.3. Overview of Peer Groups
8.4. Phosphoramidite Providers / Manufacturers: Company Competitiveness Analysis
8.4.1. Phosphoramidite Providers / Manufacturers Based in North America
8.4.2. Phosphoramidite Providers / Manufacturers Based in Europe
8.4.3. Phosphoramidite Providers / Manufacturers Based in Asia-Pacific
SECTION IV: COMPANY PROFILES
9. COMPANY PROFILES: PLAYERS BASED IN NORTH AMERICA
9.1. Meridian Life Sciences
9.1.1. Company Details
9.1.2. Service and Product Portfolio
9.1.3. Financial Details, since 2018 (USD Million)
9.1.4. Recent Developments and Future Outlook
9.2. Promega
9.2.1. Company Details
9.2.2. Service and Product Portfolio
9.2.3. Recent Developments and Future Outlook
9.3. BOC Sciences
9.3.1. Company Details
9.3.2. Service and Product Portfolio
9.4. Thermo Fisher Scientific
9.4.1. Company Details
9.4.2. Service and Product Portfolio
10. COMPANY PROFILES: PLAYERS BASED IN EUROPE
10.1. Roche
10.1.1. Company Details
10.1.2. Service and Product Portfolio
10.1.3. Financial Details, since 2021 (CHF Billion)
10.1.4. Recent Developments and Future Outlook
10.2. Merck
10.2.1. Company Details
10.2.2. Service and Product Portfolio
10.2.3. Financial Details, since 2021 (EUR Billion)
10.2.4. Recent Developments and Future Outlook
10.3. QIAGEN
10.3.1. Company Details
10.3.2. Service and Product Portfolio
10.3.3. Financial Details, since 2022 (USD Million)
10.3.4. Recent Developments and Future Outlook
11. COMPANY PROFILES: PLAYERS IN ASIA-PACIFIC
11.1. Aurisco Pharmaceuticals
11.1.1. Company Details
11.1.2. Service and Product Portfolio
11.1.3. Recent Developments and Future Outlook
11.2. Innovassynth
11.2.1. Company Details
11.2.2. Service and Product Portfolio
11.2.3. Recent Developments and Future Outlook
11.3. YAMASA
11.3.1. Company Details
11.3.2. Service and Product Portfolio
11.3.3. Recent Developments and Future Outlook
11.4. WuXi AppTech
11.4.1. Company Details
11.4.2. Service and Product Portfolio
11.5. Zhejiang Hengkang Pharmaceutical
11.5.1. Company Details
11.5.2. Service and Product Portfolio
SECTION V: MARKET TRENDS
12. RECENT DEVELOPMENTS
12.1. Chapter Overview
12.2. Partnership Models
12.3. Phosphoramidites: Partnerships and Collaborations
12.3.1. Analysis by Year of Partnership
12.3.2. Analysis by Type of Partnership
12.3.3. Analysis by Geography
12.3.3.1. Local and International Agreements
12.3.3.2. Intracontinental and Intercontinental Agreements
12.4. Funding and Investments Models
12.5. Expansion Models
13. PATENT ANALYSIS
13.1. Scope and Methodology
13.2. Phosphoramidites: Patent Analysis
13.2.1. Analysis by Patent Publication Year, Since 2022
13.2.2. Analysis by Type of Patent
13.2.3. Analysis by Type of Patent and Publication Year, Since 2022
13.2.4. Analysis by Patent Application Year, Since 2008
13.2.5. Analysis by Patent Age
13.2.6. Analysis by Type of Applicant
13.2.7. Analysis by Patent Jurisdiction
13.2.8. Analysis by CPC Symbols
13.2.9. Leading Industry Players: Analysis by Number of Patents
13.2.10. Leading Non-Industry Players: Analysis by Number of Patents
13.2.11. Leading Inventors: Analysis by Number of Patents
13.3. Patent Benchmarking Analysis
13.3.1. Analysis of Patent Characteristics (CPC Codes) by Leading Industry Players
13.3.2. Analysis of Leading Industry Players by Patent Characteristics (CPC Codes)
13.4. Patent Valuation
13.5. Leading Patents by Number of Citations
SECTION VI: MARKET OPPORTUNITY ANALYSIS
14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
14.1. Market Drivers
14.2. Market Restraints
14.3. Market Opportunities
14.4. Market Challenges
15. DEMAND ANALYSIS
15.1. Key Assumptions and Methodology
15.2. Global Annual Demand for Phosphoramidites (in Metric Tonnes)
15.2.1. Analysis by Type of Phosphoramidite
15.2.2. Analysis by Type of Oligonucleotide Synthesized
15.2.3. Analysis by Application Area
15.2.4. Analysis by Therapeutic Area
15.2.5. Analysis by geographical Regions
16. GLOBAL PHOSPHORAMIDITE MARKET
16.1. Key Assumptions and Methodology
16.2. Global Phosphoramidite Market, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
16.2.1. Multivariate Scenario Analysis
16.2.1.1. Conservative Scenario
16.2.1.2. Optimistic Scenario
16.3. Key Market Segmentations
17. PHOSPHORAMIDITE MARKET, BY TYPE OF PHOSPHORAMIDITE
17.1. Key Assumptions and Methodology
17.2. Phosphoramidite Market: Distribution by Type of Phosphoramidite
17.2.1. Phosphoramidite Market for DNA Phosphoramidites, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
17.2.2. Phosphoramidite Market for RNA Phosphoramidites, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
17.2.3. Phosphoramidite Market for 2'-Modified Phosphoramidites, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
17.2.4. Phosphoramidite Market for Locked Nucleic Acid (LNA), Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
17.2.5. Phosphoramidite Market for Other Phosphoramidites, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
17.3. Data Triangulation and Validation
18. PHOSPHORAMIDITE MARKET, BY TYPE OF OLIGONUCLEOTIDE SYNTHESIZED
18.1. Key Assumptions and Methodology
18.2. Phosphoramidite Market: Distribution by Type of Oligonucleotide Synthesized
18.2.1. Phosphoramidite Market for siRNA Oligonucleotides, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
18.2.2. Phosphoramidite Market for Antisense Oligonucleotides, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
18.2.3. Phosphoramidite Market for DNA Oligonucleotides, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
18.2.4. Phosphoramidite Market for Other Oligonucleotides, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
18.3. Data Triangulation and Validation
19. PHOSPHORAMIDITE MARKET, BY APPLICATION AREA
19.1. Key Assumptions and Methodology
19.2. Phosphoramidite Market: Distribution by Application Area
19.2.1. Phosphoramidite Market for Research and Diagnostic Applications, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
19.2.2. Phosphoramidite Market for Commercial Therapeutic Applications, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
19.2.3. Phosphoramidite Market for Clinical Therapeutic Applications, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
19.3. Data Triangulation and Validation
20. PHOSPHORAMIDITE MARKET, BY THERAPEUTIC AREA
20.1. Key Assumptions and Methodology
20.2. Phosphoramidite Market: Distribution by Application Area
20.2.1. Phosphoramidite Market for Infectious Diseases, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
20.2.2. Phosphoramidite Market for Cardiovascular Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
20.2.3. Phosphoramidite Market for Genetic Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
20.2.4. Phosphoramidite Market for Metabolic Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
20.2.5. Phosphoramidite Market for Liver Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
20.2.6. Phosphoramidite Market for Autoimmune Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
20.2.7. Phosphoramidite Market for Oncological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
20.2.8. Phosphoramidite Market for Nephrological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
20.2.9. Phosphoramidite Market for Ophthalmological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
20.2.10. Phosphoramidite Market for Neurological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
20.2.11. Phosphoramidite Market for Hematological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
20.2.12. Phosphoramidite Market for Other Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
20.3. Data Triangulation and Validation
21. PHOSPHORAMIDITE MARKET, BY KEY GEOGRAPHICAL REGIONS
21.1. Key Assumptions and Methodology
21.2. Phosphoramidite Market: Distribution by Key Geographical Regions
21.2.1. Phosphoramidite Market in North America, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.1.1. Phosphoramidite Market in the US, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.1.2. Phosphoramidite Market in Canada, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.2. Phosphoramidite Market in Europe, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.2.1. Phosphoramidite Market in Germany, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.2.2. Phosphoramidite Market in France, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.2.3. Phosphoramidite Market in Italy, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.2.4. Phosphoramidite Market in Spain, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.2.5. Phosphoramidite Market in the UK, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.2.6. Phosphoramidite Market in Rest of Europe, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.3. Phosphoramidite Market in Asia-Pacific, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.3.1. Phosphoramidite Market in China, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.3.2. Phosphoramidite Market in India, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.3.3. Phosphoramidite Market in Japan, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.3.4. Phosphoramidite Market in South Korea, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.3.5. Phosphoramidite Market in Australia, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.3.6. Phosphoramidite Market in Rest of Asia-Pacific, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.4. Phosphoramidite Market in Latin America, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.4.1. Phosphoramidite Market in Brazil, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.4.2. Phosphoramidite Market in Argentina, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.4.3. Phosphoramidite Market in Mexico, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.4.4. Phosphoramidite Market in Rest of Latin America, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.5. Phosphoramidite Market in Middle East and North Africa, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.5.1. Phosphoramidite Market in Egypt, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.5.2. Phosphoramidite Market in Israel, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.5.3. Phosphoramidite Market in Saudi Arabia, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
21.2.5.4. Phosphoramidite Market in Rest of Middle East and North Africa, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)
